DOC’S FROZEN BLUEBERRIES -Ice Cream Cake x Blueberry Preserve F3 (all proceeds donated to Seeds the Feed)

DOC’S FROZEN BLUEBERRIES -Ice Cream Cake x Blueberry Preserve F3 (all proceeds donated to Seeds the Feed)

$100.00

Doc’s Frozen Blueberry Ice Cream Cake x Blueberry Preserve f3

Gas~Fuel~Bubba Kush profiles with a perfectly complimentary effervescent-yet-confectionary blueberry are the dominant expression in this easy-to-grow creation. Some phenotypical expressions exhibit a pointed terpene profile reminiscent of a cultivar widely coveted on the front range of Colorado in the late 1990’s and early 2000’s. The Frozen Blueberry produces such large~thick flowers that humidity control is a must, but as long as the environment is dialed this cross has proven itself in testing to be a joy in every garden without exception. Very heavy yield; ~9 week flowering time; medium height Regular seeds, 12+ seeds per pack.

16 in stock

Description

Blueberry Preserve Release 

Bio: 
Seeds that Feed is a seed company born out of the idea that the cannabis industry is a reflection of the plant we love; a medicine that imparts humility, promotes empathetic understanding, and inspires us to evolve and heal. As a cannabis community we are capable of creating fantastic change, and Seeds that Feed aims to help leverage our collective efforts toward positive impacts by providing top quality genetics grown with intention, with 100% of its proceeds going to charity. 

The Blueberry Preserve Collection utilizes re-worked vintage Blueberry genetics from the 1990’s and combines them with both heirloom classics and some of the best modern cultivars, resulting in some truly unique and beautiful pairings. As the initial release from Seeds that Feed, the proceeds from Blueberry Preserve will go toward local food assistance, providing meals to those in trying times by purchasing wholesale-bought food stuffs which are delivered to food banks, soup kitchens, and community centers.

Future projects are already in the works including more exciting in-house generic releases as well as industry-bridging collaborations aimed at bringing further relief to those who need it most.